Skip to content

Scientific Technology News

About STN
Contact Us

Top-10
Instrument Industry Deals
Product Launches

Roche announces U.S. FDA approval of Xofluza to treat influenza in children aged five years and older

August 12, 2022September 7, 2022 by /

Share This.....

Share on linkedin

Share on twitter

Share on facebook

Share on google

Related News:

Roche announces the European Commission approval of…
FDA approves Roche’s Vabysmo, the first bispecific…
FDA approves Roche’s Vabysmo, the first bispecific…
FDA approves Roche’s Lunsumio, a first-in-class…
FDA grants priority review to Xolair (omalizumab)…
JEOL Leverages 50 Years of E-Beam Expertise to Bring…

Category: Acad, Gov/Utilities, Bio/Pharma/CRO Tag: Roche

Post navigation

Previous PostImproving the Working Environment and Reducing Environmental impacts by Digital transformation of the Production Lines—Shimane Shimadzu Corporation, The Medical System Manufacturing Subsidiary of Shimadzu Co.—

Next PostBruker Announces Quarterly Dividend

Get market data and industry analysis here. Request a complimentary copy.

Related News

Roche announces the European Commission approval of… January 12, 2023
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
FDA approves Roche’s Vabysmo, the first bispecific… January 31, 2022
FDA approves Roche’s Lunsumio, a first-in-class… December 23, 2022
FDA grants priority review to Xolair (omalizumab)… December 19, 2023
JEOL Leverages 50 Years of E-Beam Expertise to Bring… May 3, 2022
60 YEARS OF MASS SPECTROMETRY INNOVATION: JEOL… March 14, 2023
Bruker Acquires Nanophoton Corporation, a Japanese… February 7, 2024
KK Women’s and Children’s Hospital and PacBio… February 16, 2022
PacBio and Children’s Mercy Kansas City Expand… April 21, 2022

© 2024 Scientific Technology News